MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2)
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate if the drug ranibizumab administrated by
microdose injection into the eye is safe and effective to treat diabetic macular edema.
Phase:
Phase 2
Details
Lead Sponsor:
Especialistas en Retina Medica y Quirurgica Grupo de Investigacion